SCHEMBL78520

SCHEMBL78520

CC(C)(C)OC(=O)C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.46
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 2/20 0.34
ELANE P08246 1/20 0.34
GAA P10253 2/20 0.33
TSHR P16473 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 2/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CA12 O43570 2/20 0.31
CA14 Q9ULX7 2/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL10794464 0.93 DGAT1 (0.42) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL29399642 0.89
SCHEMBL4288100 0.87 DGAT1 (0.50) DGAT1ALDH1A1TDP1GAACA1
SCHEMBL10883850 0.87 DGAT1 (0.39) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL29625515 0.86 DGAT1 (0.42) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL11621321 0.86 DGAT1 (0.42) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL15108015 0.86 DGAT1 (0.42) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL16045685 0.86 DGAT1 (0.42) DGAT1ALDH1A1USP2SMN1; SMN2TDP1
SCHEMBL7055047 0.85 DGAT1 (0.37) DGAT1USP2SMN1; SMN2GAA
SCHEMBL9270802 0.85 DGAT1 (0.37) DGAT1USP2SMN1; SMN2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2059 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP claimed
CN-121586706-A Process for the preparation of intermediates for sartan active compounds 赛诺菲 2026-02-27 CN claimed
CN-119977783-A Synthesis method of oxaloacetic acid 上海高准医药有限公司 2025-05-13 CN claimed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO claimed
CN-119350607-A Preparation method of high molecular weight poly (alkyl oxalate) homopolymer and copolymer 青岛科技大学 2025-01-24 CN claimed
CN-119285600-A Preparation method of cyclic alkyl oxalate and ring-opening copolymerization thereof 青岛科技大学 2025-01-10 CN claimed
US-20240400824-A1 DURABLE, BROADBAND-TRANSPARENT POLYOXALAMIDE POLYMERS AND METHODS OF MAKING AND USING THE SAME HRL LABORATORIES, LLC 2024-12-05 US claimed
CN-116253872-B High-temperature-resistant polyamide resin and preparation method thereof 上海凯赛生物技术股份有限公司 2024-10-29 CN claimed
CN-118667148-A Polyamide resin and preparation method thereof 上海凯赛生物技术股份有限公司 2024-09-20 CN claimed
US-12091544-B1 Durable, broadband-transparent polyoxalamide polymers and methods of making and using the same HRL LABORATORIES, LLC (US) 2024-09-17 US claimed
EP-0552782-A1 Coated abrasive article and method of making same MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-07-28 EP claimed
EP-0540626-A1 PROCESS FOR SYNTHESIZING PEPTIDES EASTMAN CHEMICAL COMPANY (US) 1993-05-12 EP claimed
US-4740215-A DIESTER OXALATES UNION OIL COMPANY OF CALIFORNIA (US) 1988-04-26 US claimed
EP-0132770-B1 INSULIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-16 EP claimed
US-4585891-A Process for the production of dihydrocarbyl oxalates THE BRITISH PETROLEUM COMPANY P.L.C. (GB) 1986-04-29 US claimed
EP-0112171-B1 PROCESS FOR THE PRODUCTION OF DIHYDROCARBYL OXALATES The British Petroleum Company p.l.c. (GB) 1986-03-12 EP claimed
EP-0137361-A2 Insulin derivatives modified in position B 30, process for their preparation, their vuse and pharmaceutical agents for the treatment of diabetes mellitus HOECHST AKTIENGESELLSCHAFT (DE) 1985-04-17 EP claimed
EP-0132770-A1 Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus HOECHST AKTIENGESELLSCHAFT (DE) 1985-02-13 EP claimed
EP-0112171-A1 Process for the production of dihydrocarbyl oxalates The British Petroleum Company p.l.c. (GB) 1984-06-27 EP claimed
WO-1984002340-A1 PROCESS FOR THE PRODUCTION OF DIHYDROCARBYL OXALATES BRITISH PETROLEUM CO PLC (GB) 1984-06-21 WO claimed